Summary
RNA polymerase III (Pol III) produces small RNA molecules that play essential roles in mRNA processing and translation. Maf1, originally described as a negative regulator of Pol III transcription, has been studied from yeast to human. Here we characterized Maf1 in the parasitic protozoa Trypanosoma brucei (TbMaf1), representing the first report to analyse Maf1 in an early-diverged eukaryote. While Maf1 is generally encoded by a single-copy gene, the T. brucei genome contains two almost identical TbMaf1 genes. The TbMaf1 protein has the three conserved sequences and is predicted to fold into a globular structure. Unlike in yeast, TbMaf1 localizes to the nucleus in procyclic forms of T. brucei under normal growth conditions. Cell lines that either downregulate or overexpress TbMaf1 were generated, and growth curve analysis with them suggested that TbMaf1 participates in the regulation of cell growth of T. brucei. Nuclear run-on and chromatin immunoprecipitation analyses demonstrated that TbMaf1 represses Pol III transcription of tRNA and U2 snRNA genes by associating with their promoters.
Introduction
Trypanosoma brucei is a flagellated protozoan parasite that causes human African trypanosomiasis, commonly known as sleeping sickness. If left untreated, this disease produces severe neurological and psychiatric disorders leading to death. The parasite is transmitted primarily by bites from infected tsetse flies (Glossina spp). T. brucei also infects cattle, where it produces the disease nagana, causing major economic impact in subSaharan Africa (Kennedy, 2013) . The parasite possesses a complex life cycle that involves several developmental forms that alternate between the mammalian and the invertebrate hosts. In order to differentiate and adapt to the diverse environments, T. brucei requires strict control of gene expression (Kramer, 2012) .
T. brucei and other trypanosomatids, such as Trypanosoma cruzi and Leishmania spp., have unusual mechanisms of gene expression. For instance, RNA polymerase II (Pol II) transcription of protein-coding genes is polycistronic and apparently constitutive, and mature mRNAs are produced from polycistronic transcripts by trans-splicing and polyadenylation Martinez-Calvillo et al., 2010) . Transsplicing involves the addition of a capped 39-nucleotide spliced leader (SL) RNA to the 5 0 end of each mRNA (Michaeli, 2011) . In a cluster of protein-coding genes, Pol II transcription initiates mainly upstream of the first gene (Martinez-Calvillo et al., 2003; Kolev et al., 2010) ; although these regions do not seem to contain typical Pol II promoter elements, they are enriched in histone modifications and histone variants associated with transcription initiation (Siegel et al., 2009; Thomas et al., 2009; Rudenko, 2010) .
The SL RNA genes are independently transcribed by Pol II in a monocistronic fashion, and its expression is controlled by defined promoter sequences (Gunzl et al., 1997; Gilinger and Bellofatto, 2001) . Several transcription factors have been shown to bind the SL RNA promoter region in T. brucei: TATA binding protein (TBP) (Ruan et al., 2004) , SNAPc (Das et al., 2005) , TFIIA (Schimanski et al., 2005a) , TFIIB (Palenchar et al., 2006; Schimanski et al., 2006) , TFIIH (Lecordier et al., 2007; Lee et al., 2007) and the mediator complex (Lee et al., 2010) . Interestingly, the sequence of most of them is extremely divergent comparing to their orthologues in yeast and vertebrates.
In T. brucei Pol I not only synthesizes rRNAs, but also has the extraordinary ability to produce the mRNAs of the variant surface glycoproteins (VSG) and the EP/ GPEET procyclins, which are two of the most abundant proteins in the parasite (Gunzl et al., 2003) . VSGs participate in the process of antigenic variation, a survival strategy that allows bloodstream forms of T. brucei to escape host cell immunological attacks (Borst, 2002; Pays et al., 2004) . Only one Pol I transcription factor, named CITFA, has been identified and characterized in T. brucei (Brandenburg et al., 2007) . It is needed for transcription of rRNAs, VSG and procyclin genes.
Pol III is involved in the production of small essential RNAs, such as tRNAs, 5S rRNA and U6 snRNA (Dieci et al., 2007; Moir and Willis, 2013) . In trypanosomatids, Pol III transcription is also unusual, as it transcribes all snRNAs genes (not only U6) (Fantoni et al., 1994) . Moreover, snRNA genes in T. brucei have a divergently oriented tRNA gene in their 5 0 -flanking region and, interestingly, internal sequences from the neighbouring tRNA genes are required for expression of the snRNAs (Nakaar et al., 1994) . In yeast and higher eukaryotes, Pol III requires three general transcription factors to initiate transcription: TFIIIA, TFIIIB and TFIIIC (Geiduschek and Kassavetis, 2001 ). An orthologue of subunit BRF1 of TFIIIB has been characterized in T. brucei (VelezRamirez et al., 2015) . However, neither TFIIIA nor TFIIIC have been identified in this parasite.
Maf1 is a negative regulator of transcription conserved from yeast to human. It was originally discovered as a repressor of Pol III transcription in Saccharomyces cerevisiae, where Maf1 mutants showed elevated levels of tRNAs (Pluta et al., 2001) . Also, Maf1 was found to mediate several signal pathways by repressing tRNA transcription in response to diverse stresses (Boguta, 2013) . Similarly, it was reported that Maf1 reduces the levels of tRNAs, 5S rRNA and U6 snRNA in human cells (Reina et al., 2006; Goodfellow et al., 2008) . Although the overall homology among Maf1 from different species is low, all Maf1 orthologues contain three conserved sequence regions, named A, B and C, which show no homology with protein domains of known function. To inhibit transcription, Maf1 physically interacts with the C160 subunit of Pol III, and with the BRF1 subunit of TFIIIB (Desai et al., 2005; Reina et al., 2006) .
Interestingly, a study from Johnson et al. (2007) showed that human Maf1 is a negative regulator of the expression of TBP, which is a transcription factor required for all three RNA polymerases. Downregulated expression of TBP by Maf1 repressed Pol I transcription of rRNA genes (Johnson et al., 2007) . Also, a recent report showed that Maf1 controls the Pol II transcription of several genes related to cell proliferation (Lee et al., 2015) . By binding to nearby Pol III promoters, Maf1 seems to inhibit the recruitment of Pol II machinery and other factors that mediate active histone marks to Pol II promoters (Lee et al., 2015) . Thus, human Maf1 is a repressor of transcription by all three RNA polymerases (Palian et al., 2014) . Notably, it was found in yeast that Pol II transcription of two gluconeogenetic genes is downregulated by Maf1 (Morawiec et al., 2013) . Consequently, it is possible that, as in human cells, Maf1 regulates the transcription of all RNA polymerases in yeast.
In this study we characterized the Maf1 orthologue in the early-branched eukaryote T. brucei (TbMaf1). Knock-down and overexpression analyses indicate that TbMaf1 is involved in the control of cell growth in procyclic T. brucei forms, and that it inhibits transcription of Pol III-dependent genes. Interestingly, the data indicates that TbMaf1 also inhibits transcription of procyclin and SL RNA genes.
Results

Maf1 is encoded by two genes in T. brucei
Maf1 is a negative regulator of transcription that is highly conserved across eukaryotes. In order to determine if a Maf1 orthologue is present in the protozoan parasite T. brucei, BLAST analysis was performed. Two Maf1genes were identified in the T. brucei genome, one located on chromosome 4 (Tb927.4.5140) that we named TbMaf1-4, and the other one on chromosome 8 (Tb927.8.7250) that we called TbMaf1-8. Both genes encode 265-amino acid proteins, with a predicted molecular mass of approximately 30 kDa, that show 95.8% identity. A sequence alignment with human Maf1 revealed that, although the overall homology with TbMaf1-4 and TbMaf1-8 is low (15% identity), these proteins share the three conserved regions (domains A, B and C) (26%-30% identity) (Fig. 1A) , which are present in all Maf1 orthologues. The length of the sequence located between the A and B domains, known as linker region, is highly variable among species; for instance, these domains are fused in Encephalitozoon cuniculi, but they are separated by 182 amino acids in Characterization of Maf1 in T. brucei 453 A. Sequence alignment of Maf1 proteins from S. cerevisiae (ScMaf1), H. sapiens (HsMaf1) and T. brucei (TbMaf1-4 and TbMaf1-8). Conserved and semi-conserved residues are shaded in black and grey respectively. Maf1 conserved domains are boxed in red (domain A), blue (domain B) and green (domain C). For ScMaf1, only the sequences that correspond to domains A-C are shown, because the sequences of the linker and carboxy-terminal regions are larger and divergent in relation to the other Maf1 orthologues. The two Maf1 signature sequences are shown above domains B and C, with conserved residues shaded in black. The putative nuclear localization signal is underlined. Amino acids that are different between TbMaf1-4 and TbMaf1-8 are indicated with arrowheads. Arrows show amino acids that are required for Maf1 function in yeast or mammals that are conserved in T. brucei. Circles show amino acids that are phosphorylated in human (Michels, 2011) (not conserved in T. brucei). Diamonds show important amino acids for Maf1 function in yeast (Roberts et al., 2006; Gajda et al., 2010) (not conserved in T. brucei). Predicted secondary structure elements are shown below the alignment. The b-strands are represented with arrows and a-helices with rounded rectangles, and they are coloured in accordance to the conserved domain where they are located. B. Predicted three-dimensional structure of TbMaf1. Homology modelling was performed for TbMaf1 (left image) using the crystal structure of human Maf1 as a template. As control, the structure of human Maf1 was predicted (centre image). A merge between TbMaf1 and HsMaf1 is shown in the right image. The linker region and the C-terminal region of Maf1 were not included in the modelling and are represented with dashed white lines. The colours of the domains correspond to the colours shown in panel A. The putative nuclear localization signal is coloured in purple. The quality of the homology models was evaluated with the Mod Eval program, showing a score of 0.97. S. cerevisiae (Gajda et al., 2010) . In T. brucei, the linker region is composed of 36 amino acids, whereas in human it is 33 amino acids long (Fig. 1A) .
Partially-conserved Maf1 signature sequences (PDYDFS and LWSxxYFxYNKRxKR) were found within domains B and C in TbMaf1-4 and TbMaf1-8 (Fig. 1A) . Several amino acids that are required for Maf1 function in repression have been characterized in yeast and mammals (Moir et al., 2006; Roberts et al., 2006; Gajda et al., 2010; Michels, 2011) . Interestingly, four of these amino acids (S-76, D-117, S-119 and K-298) are conserved in TbMaf1 (Fig. 1A) .
A single Maf1 gene was identified in T. cruzi and Leishmania species, with the exception of L. braziliensis that contains two identical genes (Supporting Information Fig. S1 ). Relatively low conservation in the predicted amino acid sequences was found between T. brucei and T. cruzi (58.9% identity) and between T. brucei and Leishmania (47% identity) (Supporting Information Fig. S1 ). By contrast, the sequence of the Maf1 proteins is highly conserved among Leishmania species (90%-96% identities) (Supporting Information Fig. S1 ).
The secondary structure of TbMaf1 was predicted using the PSIPRED program, which indicated that domain A folds into two b-sheets and two a-helices, whereas domain B is composed of two a-helices (Fig. 1A) . Domain C is predicted to form an a-helix and three b-sheets. By contrast, no secondary structure elements are predicted for the linker region and the carboxy-terminal region (Fig. 1A) . A similar secondary structure was reported for human Maf1 (Vannini et al., 2010) . The predicted three-dimensional structure of TbMaf1 was generated by homology modelling, using as a template the crystal structure of human Maf1, which was obtained from a Maf1 variant that lacked the last a-helix from domain A, the linker region and the carboxy-terminal region (Vannini et al., 2010) ; consequently, these regions were not included in the TbMaf1 model either (Fig. 1B) . The obtained three-dimensional structure of TbMaf1 is very similar to the structure reported for human Maf1, as they both show a globular architecture with five centrally located b-sheets that are flanked by four a-helices (Fig. 1B) (Vannini et al., 2010) . Altogether, our sequence and structure analyses strongly suggest that TbMaf1-4 and TbMaf1-8 are the Maf1 orthologues in T. brucei.
TbMaf1 is a nuclear protein
In S. cerevisiae, Maf1 is normally dispersed throughout the cell, but stress conditions lead to its delocalisation to the nucleus (Roberts et al., 2006) . A putative nuclear localization signal (NKRA/TR), which overlaps with part of the signature sequence located in domain C, was identified in TbMaf1 (Fig. 1A) . Homology modelling indicates that this signal (shown in purple in Fig. 1B) is surface accessible, which suggests that TbMaf1 is a nuclear protein. Thus, to investigate the TbMaf1 cellular localization, a polyclonal antibody was generated by immunizing mice with recombinant GST-TbMaf1 protein (Supporting Information Fig. S2 ). Immunoblot analysis performed with purified nuclear and cytoplasmic protein fractions from procyclic parasites showed that the antibody reacts with an approximately 37-kDa protein only in the nuclear fraction ( Fig. 2A) . The same membrane was stripped and incubated with anti-aldolase and antiH3K18ac antibodies, which were employed as cytoplasmic and nuclear controls respectively ( Fig. 2A) . To verify the nuclear localization of TbMaf1, indirect immunofluorescence assays were carried out with the anti-TbMaf1 antibody. However, no signal was detected in these experiments (data not shown).
As an alternative approach, we produced a cell line where TbMaf1 was tagged with a carboxy-terminal PTP epitope to perform indirect immunofluorescence experiments. The PTP tag is composed of Protein A (ProtA) and Protein C (ProtC) epitopes separated by a tobacco etch virus (TEV) protease cleavage site (Schimanski et al., 2005b) . To generate the TbMaf1-PTP cell line, plasmid pC-TbMaf1-PTP was obtained by cloning the 3 0 terminal coding sequence of Tb-Maf1-8 into the genome-integration vector pC-PTP-BLA (Schimanski et al., 2005b) . Because the nucleotide sequence of TbMaf1-4 and TbMaf1-8 is almost identical, plasmid pC-PTP-BLA could integrate into either gene. Southern blot analyses using as probes the gene-specific 3 0 -UTRs (Supporting Information Fig. S3A ) showed that the vector actually integrated into the TbMaf1-4 locus (Supporting Information Fig. S3B and C). After the expression of the recombinant TbMaf1-PTP protein was confirmed by immunoblot analysis with an anti-ProtC antibody ( Fig. 2B ), indirect immunofluorescence experiments were performed using the same antibody. Analysis of the images revealed a dotted pattern inside the nucleus of the transfected parasites (Fig. 2C) . Therefore, our results showed that TbMaf1 localizes to the nucleus in procyclic forms of T. brucei.
TbMaf1 plays a role in controlling cellular growth
Studies in Drosophila melanogaster have shown that Maf1 regulates body size and developmental timing by controlling tRNA synthesis (Rideout et al., 2012) . Moreover, in several organisms Maf1 has been shown to inhibit cell proliferation and lipogenesis (Khanna et al., Characterization of Maf1 in T. brucei 455 2014; Palian et al., 2014) . Thus, in order to determine if TbMaf1 is involved in cell growth in T. brucei, we knocked-down TbMaf1 in vivo by RNA interference (RNAi). For that purpose, a 561 bp fragment from the TbMaf1-8 gene was cloned into pZJM, a vector that contains two opposite T7 RNA polymerase promoters that are inducible with doxycycline to produce doublestranded RNA (Wang et al., 2000) . Because the nucleotide sequence of TbMaf1-4 and TbMaf1-8 is almost identical, it is expected that parasites transfected with this vector would decrease the levels of mRNA from both TbMaf1 genes. The resultant vector was transfected into procyclic T. brucei cell line 29-13, which expresses the T7 RNA polymerase and the tetracycline repressor (Wirtz et al., 1999) . The transfected population was cloned by limiting dilution, and a clonal cell line was selected for further analysis.
Northern blot analysis showed that the levels of TbMaf1 mRNA were reduced by around 80% after 48 h of RNAi induction with doxycycline ( Fig. 3A ). Immunoblot analysis with the TbMaf1 polyclonal antiserum demonstrated that the amount of TbMaf1 protein was decreased by approximately 60% after 48 h of induction and by approximately 70% after 96 h of induction (Fig. 3B ). Thus, a strong reduction in the levels of TbMaf1 mRNA and protein was observed in the knock-down cell line after RNAi induction. In order to evaluate the effect of the TbMaf1 knock-down on the growth of T. brucei, cultures of induced (Dox1) and non-induced (Dox2) parasites were counted and diluted daily for seven days. As presented in Fig. 3C , which shows a representative growth curve of five independent experiments, slightly higher cell densities were reached in the induced cultures. Similar effects have been reported in other organisms, including yeast (Pluta et al., 2001) , fruit fly (Rideout et al., 2012) and worms (Cai and Wei, 2016) .
TbMaf1 is a negative regulator of transcription
The role for Maf1 in repressing Pol III transcription is conserved from yeast to mammals (Khanna et al., 2015) . In order to investigate if TbMaf1 is indeed involved in the regulation of Pol III transcription in T. brucei, nuclear run-on experiments were performed. In these assays, radiolabelled nascent transcripts were obtained from TbMaf1 knock-down cultures that were induced for 96 h (Dox1) or non-induced (Dox2) (Fig. 3D) . The Pol III-transcribed genes that we analysed were 5S rRNA, 7SL RNA, U2 snRNA, tRNA-Arg, tRNA-Phe and tRNA-Tyr. Also, a-tubulin, Elp3b and SL RNA, which are transcribed by Pol II, were included in the analysis. Two Pol I-transcribed genes, the 18S rRNA and procyclin, were also analysed. As expected, the transcription signal of the Pol III-transcribed genes was increased in the Dox1 culture (Fig. 3D) . Quantification of the hybridization signals observed in Fig. 3D and two more independent experiments (Fig. 3E ) revealed that the increase in signal varies from 80% (tRNA-Tyr) to 120% (snRNA U2). Interestingly, the increase observed with 5S rRNA (20%) was not statistically significant. Nevertheless, these results confirm that TbMaf1 inhibits Pol III transcription in procyclic forms of T. brucei. Interestingly, a reproducible increase in transcription signal was also observed for the three genes transcribed by Pol II that were analysed: a-tubulin (40%), Elp3b (30%) and SL RNA (70%) ( Fig. 3D and E) . Moreover, transcription signal for procyclin, transcribed by Pol I, showed a 60% increase after TbMaf1 RNAi induction ( Fig. 3D and E) . Notably, transcription signal of 18S rRNA, also transcribed by Pol I, remain unaffected. Therefore, these results suggest that TbMaf1 might control the transcription of some genes transcribed by Pol II and Pol I in T. brucei. The involvement of Maf1 in the regulation of Pol I and Pol II transcription has been demonstrated in other organisms (Johnson et al., 2007; Palian et al., 2014; Lee et al., 2015) .
Overexpression analysis of TbMaf1
To further explore the possible role of TbMaf1 in regulating cell growth and transcription in T. brucei, a cell line that overexpresses TbMaf1 was generated. To this end, the TbMaf1-8 coding region was cloned into pLew100 (Wirtz et al., 1999) , and the resultant vector was transfected into the procyclic T. brucei cell line 29-13. Synthesis of exogenous TbMaf1 mRNA was induced by the addition of doxycycline. RT-PCR experiments demonstrated that the levels of TbMaf1 mRNA were clearly increased after 48 h induction (Fig. 4A) . Similarly, immunoblot analysis showed that the levels of the TbMaf1 protein started to rise 48 h post-induction, reaching a 2.4-fold increase after 96 h induction (Fig. 4B ). As expected, growth curve analysis showed the opposite effect observed in the knockdown cell line (Fig. 3C) , since Maf1-overexpressing T. brucei cells (Dox1) reach lower cell densities than the non-induced (Dox2) cells (Fig. 4C) . Thus, these results support the participation of TbMaf1 in the regulation of cell growth in procyclic forms of T. brucei. Overexpression studies in human cells have demonstrated a similar growth effect (Johnson et al., 2007; Palian et al., 2014) .
The effect of the increased expression of TbMaf1 on transcription was studied by nuclear run-on analysis, using cells that were induced for 48 h (Dox1) or noninduced (Dox2). As expected, the overexpression of TbMaf1 reduced Pol III transcription (Fig. 4D ), as signal of 7SL RNA, U2 snRNA and tRNAs was reduced to approximately 45%-55% of the control value (Fig. 4E) . Thus, this data confirms that TbMaf1 is a negative regulator of Pol III transcription in T. brucei. Interestingly, signal of the 5S rRNA was reduced to a lesser extent (80%), showing non-significant differences with the control. Regarding Pol II transcription, while signal of atubulin and Elp3b was reduced to 60% and 50%, respectively, transcription of SL RNA was not significantly affected ( Fig. 4D and E) . Pol I transcription of procyclin was reduced to 60%, whereas transcription of 18S rRNA was not affected by the overexpression of TbMaf1 ( Fig. 4D and E) . Altogether, our results suggest that TbMaf1 could participate in the expression of some RNAs transcribed by Pol II and Pol I in T. brucei.
TbMaf1 associates with promoter regions
To investigate the in vivo binding of TbMaf1 to T. brucei promoter regions, chromatin immunoprecipitation (ChIP) experiments were conducted. For these assays, we used the cell line that expresses the PTP-tagged version of TbMaf1, and immunoprecipitations were performed with a ChIP-grade anti-ProtA antibody, which recognizes the two ProtA domains present in the PTP tag (Lee et al., 2010) , and with a nonspecific rabbit immune serum as negative control. Recovered DNA was analysed by qPCR to explore the binding of TbMaf1-PTP to different regions of the T. brucei genome (Fig. 5A ). Four Pol III promoter regions were analysed: the internal promoter found in tRNA-Arg, tRNA-Ala and 5S rRNA genes, and the extragenic promoter from the U2 snRNA gene. As negative controls, we analysed fragments Characterization of Maf1 in T. brucei 457 located upstream of the two tRNA genes (tRNA inter) and the U2 snRNA gene (which do not contain an internal promoter region) (Fig. 5A) . The results from three independent experiments showed that, as anticipated, TbMaf1-PTP is highly enriched in the tRNA genes and the U2 snRNA promoter (Fig. 5B) . Lower enrichment of TbMaf1 was found in the 5S rRNA genes (Fig. 5B) . As expected, TbMaf1 did not bind the tRNA intergenic regions and the U2 snRNA gene. Thus, these data confirm the involvement of TbMaf1 in Pol III transcription in T. brucei. Several fragments from Pol I-and Pol IIdependent genes were also analysed. Regarding Pol II transcription, TbMaf1 was enriched in the SL RNA promoter, but not in a fragment from the intergenic region of the SL RNA tandem array, the a-tubulin gene and a fragment from the strand switch region (SSR) upstream of the transcription unit that contains the a-tubulin genes (Fig.  5B) . Interestingly, TbMaf1-PTP was enriched in the Pol I promoter region of the procyclin gene, but absent from the Pol I promoter of the rRNA transcription unit (Fig. 5) . As expected, we did not observe association of TbMaf1 with the procyclin and 18S rRNA genes. Consequently, these results confirm that TbMaf1 has a role in regulating Pol I transcription of the procyclin gene and Pol II transcription of the SL RNA gene in procyclic forms of T. brucei.
Discussion
In this work we identified and characterized Maf1 in the protozoan parasite T. brucei. Our results show that TbMaf1 is a negative regulator of transcription, a function that is conserved in multiple organisms including yeast, insects, worms, vertebrates and plants (Soprano et al., 2013; Khanna et al., 2015) . Thus, the presence of Maf1 in T. brucei, an early diverging eukaryote, suggests that Maf1 was most likely present in the last eukaryotic common ancestor, as has been suggested for other proteins with wide phylogenetic distribution (Rathore et al., 2016) . This is different from other regulators of Pol III and Pol I transcription, such as Myc, p53 and Rb, which have been studied in higher eukaryotes (White, 2008) , but do not seem to be present in trypanosomatids.
It is worth noting that, while all species studied contain a single Maf1 gene, T. brucei possesses two nonidentical Maf1 genes, namely TbMaf1-4 and TbMaf1-8. Interestingly, 3 0 -UTR sequences differ considerably between TbMaf1-4 and TbMaf1-8, as they show only 32% identity (Supporting Information Fig. S3A ).
Because sequences within 3 0 -UTRs play a major role in post-transcriptional regulation in T. brucei (Clayton, 2013) , it is tempting to speculate that the expression of TbMaf1-4 and TbMaf1-8 is differentially regulated and that they might participate in some gene-specific functions. Attempts to specifically downregulate TbMaf1-4 or TbMaf1-8 by RNAi using the 3 0 -UTRs were unsuccessful, since the abundance of the mRNAs was not reduced after the induced production of double-stranded RNA (Supporting Information Fig. S4 ). Interestingly, while TbMaf1-8 mRNA was observed as a sharp and discrete band in Northern blot experiments, transcription of TbMaf1-4 produced a smeared band that seems to contain a population of mRNAs of different sizes (Supporting Information Fig. S4 ). This observation is supported by high-throughput RNA sequencing analysis that revealed that the length of the 3 0 -UTR from TbMaf1-8 is constant (it ranges from 410 to 424 bases), whereas the length of the 3 0 -UTR from TbMaf1-4 is heterogeneous (it varies from 400 to 1300 bases) (Kolev et al., 2010) . The Northern blot analysis also reveals that TbMaf1-4 is highly upregulated compared with TbMaf1-8 (Supporting Information Fig. S4 ). The higher expression levels of TbMaf1-4 may explain why the PTP vector only integrated into this locus, as differential levels of transcription would lead to selective drug sensitivity of transfectants between the two loci. A single Maf1 gene is present in all the species of Leishmania, except for L. brazileinsis that possesses two identical Maf1 genes. Unlike T. brucei, Maf1 is a single-copy gene in T. cruzi. Analysis of the TriTrypDB databases of other Trypanosoma species showed that T. congolense, T. evansi and T. vivax contain two Maf1 genes. Thus, the number of Maf1 genes seems to be variable within trypanosomatids. Interestingly, no single Maf1 gene was identified in the T. rangeli genome; moreover, there are no Maf1 degenerate sequences A. Northern blot analysis of TbMaf1 mRNA in non-induced parasites (Dox2) and parasites induced for 24 or 48 h. To normalize the TbMaf1 mRNA levels, the filter was stripped and re-hybridized with an a-tubulin probe. Densitometric analysis from this hybridization and two independent experiments is shown below the blot. B. Immunoblot analysis of TbMaf1 protein in non-induced parasites (Dox2) and parasites induced for 24, 48, 72 and 96 h using the TbMaf1 antiserum. The bands shown here and from two independent experiments were quantified and plotted. TbMaf1 protein levels were normalized to the level of the b-tubulin protein (loading control). C. Growth curve of a clonal cell line under non-induced (Dox2) and doxycycline-induced (Dox1) conditions. A representative growth curve of five independent experiments is shown. The average doubling times were 12.6 and 10.7 h for the Dox2 and Dox1 cultures respectively. Statistical significance was determined by two-sample t-test (P < 0.0001). D. Run-on assay conducted with isolated nuclei from a clonal cell line that was either induced with doxycycline for 96 h (Dox1) or noninduced (Dox2). Labelled nascent RNA was used to hybridize dot blots of double-stranded DNAs (2 lg) cloned into the pGEM-T Easy vector. The genes transcribed by Pol III analysed were: 5S rRNA (5S), 7SL RNA (7SL), U2 snRNA (U2), tRNA-Arg (Arg), tRNA-Phe (Phe) and tRNATyr (Tyr). The Pol I-transcribed 18S rRNA (18S) and procyclin (Procyc) were also analysed. Also, three genes transcribed by Pol II were studied: a-tubulin (a-tub), Elp3b (Elp3) and SL RNA. An empty vector (pGEMT) was analysed as control. E. The signals obtained for each gene in panel D, and from two more independent experiments, were quantified and plotted, considering as 100% the signal obtained in the Dox2 experiment. Values represent means of the three experiments. Standard deviation bars are shown. RNA levels were normalized to the level of the 18S rRNA. Statistical significance was determined by two-sample t-test. *P < 0.05; **P < 0.001; ***P < 0.0001.
Fig. 4. Overexpression analysis of TbMaf1.
A. The levels of TbMaf1 mRNA were assayed by RT-PCR in cells that were induced with doxycycline for 48 h (Dox1) to overexpress Maf1, or non-induced (Dox2). Densitometric analysis from three independent experiments is shown below the gel. As a control, a fragment of a-tubulin was amplified too. B. Immunoblot analysis of TbMaf1 protein in non-induced parasites (Dox2) and parasites induced for 24, 48, 72 and 96 h using the TbMaf1 antiserum. Densitometric analysis of three independent experiments is shown below. TbMaf1 protein levels were normalized to the level of the b-tubulin protein (loading control). C. Growth curve of a clonal cell line under non-induced (Dox2) and doxycycline-induced (Dox1) conditions. A representative growth curve of three independent experiments is shown. The average doubling times were 13.6 and 17.5 h for the Dox2 and Dox1 cultures respectively. Statistical significance was determined by two-sample t-test (P < 0.002). D. Run-on assay performed with isolated nuclei from a clonal cell line that was either induced with doxycycline for 48 h (Dox1) or non-induced (Dox2). Labelled nascent RNA was used to hybridize dot blots of double-stranded DNAs (2 lg) cloned into the pGEM-T Easy vector, as indicated in Fig. 3D . E. The signals obtained for each gene in panel D, and from two more independent experiments, were quantified and plotted, considering as 100% the signal obtained in the Dox2 experiment. Values represent means of the three experiments. Standard deviation bars are shown. RNA levels were normalized to the level of the 18S rRNA. Statistical significance was determined by two-sample t-tests. *P < 0.05; **P < 0.001; ***P < 0.0001.
(pseudogenes) in the corresponding regions of synteny. Further analysis is required to demonstrate the absence of Maf1 in T. rangeli and its possible biological implications.
Our results showed that the TbMaf1-4 and TbMaf1-8 proteins possess all the sequence and structural features present in Maf1 orthologues from other organisms (Fig. 1) . For example, sequence comparisons revealed that TbMaf1-4 and TbMaf1-8 contain domains A, B and C, which are conserved in Maf1 proteins across eukaryotes. The two Maf1 signature sequences located on domains B and C are present in TbMaf1-4 and TbMaf1-8 as well. The predicted tridimensional structure obtained by homology modelling showed that TbMaf1 forms a globular structure with five centrally located bsheets that are flanked by one a-helix on one side and three a-helices on the other side (Fig. 1B) . This structure is very similar to the one reported for human Maf1 (Vannini et al., 2010) . For the most part, domains A, B and C seem to correspond to independently folded structural modules. The putative nuclear localization signal, which overlaps with part of the signature sequence located in domain C, is exposed at the surface of the globular protein structure (Fig. 1B) . The apparent molecular mass of TbMaf1 (37 kDa) ( Fig. 2A) is a little higher than its predicted mass (30 kDa). This fact has been reported for Maf1 in several species, and it is apparently caused by post-translational modifications (Oler and Cairns, 2012; Rohira et al., 2013) . It remains to be determined if the function of TbMaf1 is regulated by post-translational modifications.
Immunoblot ( Fig. 2A ) and indirect immunofluorescence (Fig. 2C) analyses showed that TbMaf1 localizes to the nucleus in exponentially-growing procyclic forms of T. brucei. In contrast, in S. cerevisiae Maf1 is spread throughout the cell under normal growth conditions, and unfavourable conditions lead to its enrichment to the nucleus (Roberts et al., 2006) . In two different types of human cancer cells, Maf1 has been either localized to the nucleus (Rollins et al., 2007) , or distributed evenly throughout the cell (Shor et al., 2010) . In the latter case, mTOR inhibitors caused nuclear accumulation of Maf1. It has been shown that Maf1 and BRF2 (a subunit of transcription factor TFIIIB in vertebrates) co-localize in human cells (Rollins et al., 2007) . In agreement with this result, the punctate nuclear distribution of TbMaf1 (Fig. 2C ) strongly resembles the nuclear pattern reported for BRF1 in T. brucei (Velez-Ramirez et al., 2015) .
Nuclear run-on analyses with cell lines where TbMaf1 was either depleted (Fig. 3D) or overexpressed (Fig. 4D) showed that TbMaf1 is a negative regulator of Pol III transcription in procyclic forms of T. brucei. Moreover, ChIP experiments demonstrated that TbMaf1 associates with promoter regions from tRNA-Arg, tRNAAla, U2 snRNA and 5S rRNA genes (Fig. 5) . Similarly, ChIP on chip analyses in yeast showed the binding of Maf1 to Pol III-transcribed genes in conditions of active growth, with an increased association of Maf1 under unfavourable growth conditions (Oficjalska-Pham et al., 2006; Roberts et al., 2006) . High levels of Maf1 were found to reduce 5S rRNA transcription in mammalian cells (Reina et al., 2006; Goodfellow et al., 2008) . Also, increased transcription of 5S rRNA genes was observed in Maf1-deficient yeast extracts (Pluta et al., 2001) . Notably, although our data indicates that TbMaf1 binds 5S rRNA genes (Fig. 5) , we did not observe significant changes in the transcription of 5S rRNA after TbMaf1 depletion or overexpression (Figs. 3E and 4E) . Thus, the role of TbMaf1 in the regulation of 5S rRNA transcription in T. brucei requires further investigation.
Our results also indicate that TbMaf1 is involved in the regulation of some genes transcribed by Pol I and Pol II. Regarding Pol I-dependent genes, procyclin transcription was reproducibly increased after TbMaf1 depletion (Fig. 3E ) and decreased after TbMaf1 overexpression (Fig. 4E) , whereas 18S rRNA transcription was not affected. Accordingly, our ChIP assays revealed that TbMaf1 associates with the procyclin promoter region, but not with the promoter region from the rRNA unit (Fig. 5) . It is worth noting that promoter regions of procyclins and rRNA genes are similar, but not identical, and it is expected that they recruit different transcription factors (Sherman et al., 1991; Laufer et al., 1999) . Therefore, it is possible that TbMaf1 associates with the procyclin promoter by interacting with a procyclinspecific transcription factor. In mammalian cells, Maf1 regulates 18S rRNA transcription by directly controlling the expression of TBP (Johnson et al., 2007) , which is a subunit of several transcription factors, including the Pol I transcription factor SL1. In T. brucei, TBP is required for transcription of procyclin genes, but it is not apparently needed for transcription of the rRNA unit (Ruan et al., 2004; Thomas et al., 2006) . Interestingly, RT-PCR and qPCR analyses indicate that TBP expression is not affected after TbMaf1 ablation or overexpression in T. brucei (Supporting Information Fig. S5 ). Thus, unlike other organisms, TBP does not seem to play an important role in Maf1 regulation of transcription in T. brucei.
Depletion of TbMaf1 increased 30%-40% the Pol II transcription signal of a-tubulin and Elp3b (Fig. 3E) , whereas, in agreement, overexpression of TbMaf1 reduced to 50%-60% the transcription of these genes (Fig. 4E) . The nuclear run-on results obtained for the SL RNA gene were somehow contradictory, since transcription signal was increased 70% after TbMaf1 ablation (Fig. 3E) , and not significantly affected after TbMaf1 overexpression (Fig. 4E) . Since SL RNA is encoded by multiple genes, and each of them contains its own promoter region, it is possible that in the overexpression experiments the levels of Maf1 were not high enough to reduce the transcription from every SL RNA gene. However, ChIP analysis showed the association of TbMaf1 with the SL RNA gene promoter (Fig. 5) . Thus, these results show the participation of TbMaf1 in the transcriptional regulation of SL RNA. In human cells, Maf1 regulates Pol II transcription of genes related to cell proliferation, including CDKN1A (cyclin-dependent kinase inhibitor 1A), that contain tRNA-derived SINEs (short interspersed elements) in their promoter regions (Lee et al., 2015) . Under normal conditions, Pol III binds the SINE within the CDKN1A promoter, which in turn induces CDKN1A transcription by recruiting Pol II, general transcription factors and other proteins that generate histone modifications associated with gene activation. Adverse growth conditions lead to the binding of Maf1 to the SINE, which prevents the recruitment of Pol III and Pol II machinery to inhibit CDKN1A transcription (Lee et al., 2015) .
In human and Caenorhabditis elegans, Maf1 negatively regulates genes required for de novo lipogenesis by binding to their promoter regions (Palian et al., 2014; Khanna et al., 2014) . In yeast, Maf1 represses Pol II transcription of two gluconeogenetic genes by an unknown mechanism (Morawiec et al., 2013) . Microarray analysis in C. elegans showed that Maf1 controls the expression of numerous Pol II-transcribed genes involved in essential functions, such as protein synthesis, growth and reproduction (Khanna et al., 2014) . Interestingly, a whole-body knock-out of Maf1 in mice showed no significant changes in the levels of Pol II transcripts (Bonhoure et al., 2015) .
If, indeed, TbMaf1 inhibits Pol II transcription of protein-coding genes in T. brucei, the mechanism must be different from those present in other organisms, considering that Pol II transcription in this parasite is polycistronic and that mRNA abundance is mainly regulated at a post-transcriptional level (Clayton, 2013) . Notably, we did not observe the association of TbMaf1 with a 250-bp fragment from the SSR located upstream of the a-tubulin locus (Fig. 5) . However, we cannot rule out the possibility that TbMaf1 binds to other parts of the SSR, which is 3.6 kb long. In contrast, our data show the binding of TbMaf1 to the upstream element of the SL RNA promoter region (Fig. 5) . Even though domain IV of the rRNA gene promoter and the upstream element of the SL RNA promoter share sequence similarity (Schimanski et al., 2004) , TbMaf1 does not associate to the former (Fig. 5) . This suggests that TbMaf1 might recognize Pol II transcription factors associated with the SL RNA promoter, which are not present in the rRNA gene promoter.
In conclusion, our results demonstrate that, unlike most organisms, TbMaf1 is encoded by two genes in the protozoan parasite T. brucei. Both TbMaf1 proteins contain the three typical Maf1 domains and are predicted to fold into a conserved globular structure. Our data also show that TbMaf1 localizes to the nucleus in T. brucei procyclic forms. Growth analysis of cell lines that either downregulate or overexpress TbMaf1 suggests that TbMaf1 has a role in controlling cell growth of T. brucei. As expected for a Maf1 orthologue, our results show that TbMaf1 inhibits transcription of Pol IIIdependent genes. Moreover, our data indicates that TbMaf1 also regulates Pol I transcription of the procyclin gene and Pol II transcription of the SL RNA genes. Therefore, the function of Maf1 is highly conserved through evolution.
Experimental procedures
In silico analyses
Sequences were obtained from the TriTrypDB database (release 27) (http://tritrypdb. org/tritrypdb/) and from the National Center for Biotechnology Information (NCBI) database (http://www. ncbi.nlm.nih.gov/). Multiple sequence alignments were produced with the Clustal Omega program (http://www.ebi.ac.uk/Tools/msa/clustalo/). The most suitable sequence of Maf1 for RNAi experiments was chosen using the TrypanoFAN page (http://trypanofan.path.cam.ac.uk/trypanofan/main/). To predict the protein secondary structure, the PSIPRED Protein Sequence Analysis Workbench was used (http://bioinf.cs.ucl.ac.uk/psipred/). Homology modelling was performed with SWISS-MODEL (http://swissmodel. expasy.org/interactive) and Swiss-PDBViewer program (http://www.expasy.org/spdbv/), using the crystallographic structure of human Maf1 (PDB id: 3nr5) as a template.
Cell culture and transfection
The procyclic form of T. brucei strain 29-13 (Wirtz et al., 1999) was cultured at 288C in SDM-79 medium supplemented with 10% fetal bovine serum (GIBCO), 15 mg ml 21 G418 (Sigma) and 50 mg ml 21 hygromycin B (Sigma). Transfections were performed as previously described (Velez-Ramirez et al., 2015) . Transfectants were selected with phleomycin (2.5 mg ml 21 ) (for RNA interference) or with blasticidin (10 mg ml 21 ) (for PTP-tagging and Maf1 overexpression). Clonal cell lines were obtained by serial dilution in 96-well plates. Silencing and overexpression of TbMaf1 was induced by adding doxycycline (2 mg ml
21
) to the medium (Dox1 or induced culture). As a control, the same cell line was grown without doxycycline (Dox2 or non-induced culture) in parallel with the induced culture. Parasites were counted daily and diluted to 2 3 10 6 cells ml
. For growth curves, cumulative cell density was plotted. Doubling times of the different cell lines were calculated as previously reported (Shi et al., 2004) .
Plasmids
To obtain plasmid pZ-TbMaf1 for RNAi experiments, a 561-bp fragment from the TbMaf1-8 gene (Tb927.8.7250) was amplified with primers RNAi-Fw (5 0 -AGGTCCAGCTTG-GAGGCTTTCCATGTCGTT) and RNAi-Rv (5 0 -CTTATCTTT GCGGAGGGAAACTCGAGT) and cloned into the pZJM vector (Wang et al., 2000) using the XhoI and BamHI restriction sites. Before transfection, pZ-TbMaf1 was linearized with NotI. The 3 0 -UTR of TbMaf1-4 (Tb927.4.5140) was amplified with oligonucleotides Maf4iRNAFw (5 0 -GGAT CCAAGCTTTGTGATTGATAGTGGAGCGG) and Maf4iR-NARv (5 0 -TTCTTTCCGTACTTCCACCGCTCGAG); while the 3 0 -UTR of TbMaf1-8 was amplified with primers Maf8iR-NAFw (5 0 -GGATCCAAGCTTTACTGGAGCTAGGAAGAGGA) and Maf8iRNARv (5 0 -TATTCCATCGTGTGTGCTCCCTCGA G). Both regions were also cloned into pZJM. To generate vector pLew-TbMaf1 for overexpression of TbMaf1, gene Tb927.8.7250 was amplified with primers HindIII-Fw (5 0 -AA GCTTTTCTAATGGAGTTCGTTC) and BamHI-Rv (5 0 -TATTA TTATCGCCCGTGAGGATCC) and cloned into pLew100v5-BSD vector (Wirtz et al., 1999) , using the restriction sites indicated in the primer's name. For transfection, pLewTbMaf1 was linearized with NotI. To obtain vector pC-TbMaf1-PTP for PTP tagging, a 489-bp fragment from the C-terminal TbMaf1 coding region was amplified with primers PTP-Fw (5 0 -GGGCCCCTAAACAGCATTTATGGTGAG) and PTP-Rv (5 0 -GTACATTATTATTATCGCCCGGCGCGGCC GC) and cloned into the ApaI and NotI restriction sites of the Characterization of Maf1 in T. brucei 463 pC-PTP-Bla plasmid . Prior transfection, the plasmid was linearized with NcoI. To obtain vector pX-TbMaf1 for the expression of recombinant GST-TbMaf1 protein, the entire TbMaf1 gene was amplified with oligonucleotides BamHi-Fw (5 0 -CGGGATCCATGGAGTTCGTTC CCCTCGAG) and NotI-Rv (5 0 -GTACATTATTATTATCGCCC GGCGGCCGC) and cloned into the pGEX-4T3 vector (GE healthcare) using the restriction sites indicated in the primer's name. All constructs were verified by sequencing.
Indirect immunofluorescence
These assays were performed as previously described (Velez-Ramirez et al., 2015) , using 1.5 3 10 7 mid-log parasites that expressed the recombinant TbMaf1-PTP protein.
Cells were incubated with a rabbit anti-ProtC polyclonal antibody (Delta Biolabs) and a secondary goat anti-rabbit antibody conjugated with Alexa-Fluor 488 (Life Technologies). Images were obtained with a Zeiss Axiovert A1 microscope and analysed with the LEN2 software.
Protein extraction and immunoblot analysis
Whole-cell extracts were obtained by standard procedures (Ji, 2010) . Nuclear and cytoplasmic fractions were obtained from 1.8 3 10 6 parasites, which were harvested and washed once with lysis buffer (10 mM Tris pH 7, 3 mM CaCl 2 , 2 mM MgCl 2 ). The pellet was resuspended in lysis buffer with 0.5% NP-40 and protease inhibitor cocktail (Sigma). Cells were transferred to a Dounce homogenizer and broken with 20-30 strokes. The extract was centrifuged at 1500g for 10 min and the supernatant was recovered and kept at 2208C as the cytoplasmic fraction. The pellet was resuspended in extraction buffer (20 mM HEPES, 420 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.5 mM DTT, protease inhibitor cocktail) and incubated for 40 min in a tube rotator. The extract was centrifuged and the supernatant was collected and kept at 2208C as the nuclear fraction. All steps were performed at 48C. For immunoblot analysis, 50-80 mg of protein were fractionated on SDS-10% polyacrylamide gels and blotted to PVDF membranes (Bio-Rad). Membranes were incubated with monoclonal anti-ProtC antibody HPC4 (1:250 dilution, Roche), polyclonal anti-TbMaf1 antiserum (1:3000 dilution), polyclonal anti human b-tubulin (1:500, Invitrogen), polyclonal anti-human acetyl-histone H3 (Lys 18) (1:25 000, Millipore), or antiPlasmodium aldolase antibody (1:25 000, Abcam). Proteins were detected with a horseradish peroxidase-conjugated secondary antibody, and developed using an ECL kit (GE Healthcare).
Northern and Southern blot analyses
For Northern blot experiments, total RNA was extracted with TRI reagent (Sigma), separated in agaroseformaldehyde gels and transferred to Hybond-N filters (Amersham). Hybridization was performed with an approximately 500-pb probe from the TbMaf1 gene that was labelled with [a-32 P]dCTP using the High Prime labelling system (Amersham). This fragment was amplified by PCR with primers TbMaf1-RNAiF (5 0 -AGGTCCAGCTTGGAGGC TTTCCATGTCGTT) and TbMaf1-RNAiR (5 0 -CTTATCTTT GCGGAGGGAAACTCGAGT). Filters were washed to a final stringency of 0.13 SSC and 0.1% SDS at 658C. Other experiments were carried out with approximately 300-bp probes corresponding to the 3 0 -UTRs of TbMaf1-4 or T bMaf1-8, which were amplified as described in the Plasmids section. For Southern blot analysis, 5 mg of genomic DNA, isolated as reported elsewhere (Carrington, 1993) , were digested with AgeI, BamHI, MfeI and SphI (New England Biolabs). DNA was separated by electrophoresis and transferred by capillary to Hybond-N membranes. The radioactive probes corresponded to the 3 0 -UTRs of TbMaf1-4 or TbMaf1-8. Filters were washed as described above.
Generation of TbMaf1 polyclonal antibody
Plasmid pX-TbMaf1 was transformed into Escherichia coli JM109 competent cells, and expression of the GST-TbMaf1 recombinant protein was induced with 0.5 mM IPTG. Protein was purified by glutathione-affinity chromatography (GE Healthcare) according to the manufacturer's specifications. Purified recombinant protein (30 mg) was used to inoculate 4-week-old female BALB-C mice intraperitoneally in complete Freund's adjuvant (Sigma) at a 1:1 ratio. Animals were boosted after 3 and 6 weeks with a similar dose of the antigen in incomplete Freund's adjuvant (Sigma). Serum was collected 15 days after the last immunization. Pre-immune normal mouse serum was collected before immunization.
Nuclear run-on analysis
These assays were conducted as described previously (Padilla-Mejia et al., 2015; Velez-Ramirez et al., 2015) , using isolated nuclei from 2 3 10 8 mid-log cells incubated in the presence of doxycycline for 96 h (for knock-down studies) or 48 h (for overexpression analysis). Labelled nascent RNA was hybridized to Hybond-N1 filters (Amersham) containing dots of 2 mg of plasmid DNA. These plasmids contain fragments of genes transcribed by Pol I (18S rRNA and procyclin), Pol II (a-tubulin, Elp3b and SL RNA) and Pol III (5S rRNA, 7SL RNA, U2 snRNA, tRNA-Arg, tRNAPhe and tRNA-Tyr), as published recently (Velez-Ramirez et al., 2015) . After hybridization, filters were washed to a final stringency of 0.13 SSC and 0.1% SDS at 658C. RNA signals were quantified by densitometry using the MultiGauge software.
RT-PCR assays
To analyse the TbMaf1 mRNA levels in the TbMaf1 overexpression studies, RT-PCR assays were performed with the SuperScript One-Step RT-PCR with Platinum Taq System (Invitrogen), following the manufacturer's instructions. TbMaf1 (Tb927.8.7250) was amplified with primers HindIII-Fw (5 0 -AAGCTTTTCTAATGGAGTTCGTTC) and BamHI-Rv (5 0 -TATTATTATCGCCCGTGAGGATCC). The a-tubulin (Tb927.1.2340) transcript was amplified with the primers Alfa-tub 5 0 (5 0 -AGAAGTCCAAGCTCGGCTACAC) and Alfa-tub 3 0 (5 0 -CTTCAAGTGCGGCATCAACTAC). For TBP mRNA quantification after TbMaf1 knock-down, the TBP transcript (Tb927.10.1550) was amplified with oligonucleotides TBP 5 0 (5 0 -CCTCTGGTCTTCTTGGCATC) and TBP 3 0 (5 0 -CAACTTCTCCAGCGTCCAGT); and TbMaf1 was amplified with the oligonucleotides Maf1qFw (5 0 -ATTCTTTGCTTCAGGGTGTG) and Maf1qRv (5 0 -GAAGCCGTATGACGTCCGCTT). Amplification products were resolved by electrophoresis in agarose gels stained with ethidium bromide and signals were quantified by densitometry using the MultiGauge software.
Chromatin immunoprecipitation analysis
ChIP experiments were carried out as previously described (Park et al., 2011; Vizuet-de-Rueda et al., 2016) , with some modifications. For each assay, 1 3 10 8 parasites were cross-linked with formaldehyde (final concentration of 1%) for 5 min at 378C. Cells were broken with a Vibra-Cell VCX130 ultrasonic processor (Sonics) (15 s on/off, 40% amplitude) for 5 min. Nuclei were pelleted and resuspended in sonication buffer (1% SDS, 10 mM EDTA, 50 mM TrisHCl pH 8.1). Chromatin was sonicated to an average DNA size of about 200-500 bp using a BioRuptor UCD-200 (Diagenode) (30 s on/30 s off, high intensity) for 40 cycles. The sonicated material was pre-cleared by adding protein A/G plus-agarose beads (Santa Cruz Biotechnology) and rotating for 1 h at 48C. Chromatin samples were incubated overnight at 48C with rabbit anti-ProtA antibody (Sigma) or nonspecific rabbit immune serum as negative control. The protein-DNA complexes were incubated for 1 h with protein A/G plus-agarose beads and 200 ng of sonicated salmon sperm DNA, and washed as previously described (Vizuetde-Rueda et al., 2016) . Cross-links were reversed with 200 mM NaCl at 658C overnight. Following RNase A and proteinase K treatment, DNA was precipitated with sodium acetate and ethanol and quantified. Each ChIP experiment was performed at least three times.
Quantitative real-time PCR
Around 2 ng of immunoprecipitated DNA was analysed by quantitative real-time PCR (qPCR) using the Platinum SYBR Green qPCR SuperMix-UDG kit (Invitrogen). Data were analysed by the 2 2DDCq method, as reported previously (Velez-Ramirez et al., 2015; Vizuet-de-Rueda et al., 2016) . All qPCR reactions were performed in triplicate, using primers and conditions that were optimized to produce a single amplicon of the correct size. Results are presented as fold enrichment over negative control precipitations. Domain IV of the rRNA promoter (18S-IV) was amplified with oligonucleotides 18S4Fw (5 0 -CACCCTCAAGACCGTAGCTC) and 18S4Rv (5 0 -TGTGTTGATAAGGGACGGGT); and domains I/II (18S-I/II) with primers 18S1-2Fw (5 0 -CTGTGGGGAACACACAAACA) and 18S1-2Rv (5 0 -TGGTGTTTCCCTCTACAGGG). The 18S rRNA gene (Tb927.2.1452) was amplified with oligonucleotides 18SrRNA-5 0 (5 0 -CGGCTTCCAGGAATGAAGG) and 18SrRNA-3 0 (5 0 -CCCCTGAGACTGTAACCTC). Procyclin gene (Tb927.6.510) was amplified with primers Procyclin-5 (5 0 -ATGGCACCTCGTTCCCTTTA) and ProcqRv (5 0 -CTTTG CCTCCCTTCACGATAAC); and the procyclin promoter region with primers GPEET-promoter-F (5 0 -TGATAGGTATCTCTTAT-TAGTATAG) and GPEET-promoter-R (5 0 -GTACTCACCCG ATAACCCC), as reported previously (Lee et al., 2010) . The strand switch region (SSR) fragment was amplified with oligonucleotides SSRatub5 0 (5 0 -GGTGGGCGTGTATTCTTTGT) and SSRatub3 0 (5 0 -TATGTGTTTTCGGTCTGGGG); and the a-tubulin gene (Tb927.1.2340) with TubqFw (5 0 -GGGCTTCC TCGTGTATCA) and TubqRv (5 0 -GCTTGGACTTCTTGCC ATAG). The SL RNA promoter region was amplified with oligonucleotides SL-promoter-F (5 0 -CTACCGACACATTTCTGG C) and SL-promoter-R (5 0 -GCTGCTACTGGGAGCTTCTC ATACC); and SL RNA intergenic region with primers SL-inter-F (5 0 -ATGGCTTATACGTGCTCGTTTCTCC) and SL-inter-R (5 0 -AGCAGACTTTAAAGCGCCTATATGTG) (Lee et al., 2010) . The rRNA 5S gene (Tb927.8.1381) was amplified with primers 5SrRNA-F1 (5 0 -GAGTACGACCACACTTG AGTG) and 5SrRNA-R1 (5 0 -GAGTACGGCACTCAGGGTT). The tRNA-Ala gene (Tb927.7.6821) was amplified with oligonucleotides AlaqFw (5 0 -GGGGATGTAGCTCAGATGG) and AlaqRv (5 0 -TGGAGAAGTTGGGTATCGATC); and the tRNA-Arg gene (Tb927.8.2859) with oligonucleotides ArgqFw (5 0 -GGTCTCGTGGCGCAATG) and ArgqRv (5 0 -CGATCCC GGCAGGACTC), as reported before (Velez-Ramirez et al., 2015) . The intergenic region upstream of the tRNA-Ala gene was amplified with oligonucleotides InterAla5 0 (5 0 -CACTC TCCCGAGAATCGAAG) and InterAla3 0 (5 0 -AAAAGTCGAC TCCACACCCA); and the intergenic region upstream of the tRNA-Arg gene with primers InterArg5 0 (5 0 -GGCTGAAAATAG CGGAAGTG) and InterArg3 0 (5 0 -GACTAACGACACGGGCT AGC). The U2 promoter region was amplified with primers U2Prom5 0 (5 0 -CACAACCTGTAGTGGCGGTA) and U2Prom3
0
(5 0 -TTACGACACCTGGTCCATTG); and U2 snRNA gene (Tb927.2.5680) with primers U2qFW (5 0 -CTCGGCTATTT AGCTAAGATCAAGT) and U2qRV (5 0 -AAACTGTTGGCTGT CCCG). To analyse the TBP mRNA levels after TbMaf1 overexpression, 1 lg of total RNA from the 48 h induced and non-induced parasites was used as template for the first strand cDNA synthesis using SuperScript TM III Reverse Transcriptase (Invitrogen) and 50 ng of random hexamers (Invitrogen). The cDNA was analysed by quantitative real-time PCR (qPCR) assays using the Platinum SYBR Green qPCR SuperMix-UDG kit, as explained above, and the obtained data was analysed by the 2 2DDCq method. The a-tubulin gene was amplified with primers TubqFw (5 0 -GGGCTTCCT CGTGTATCA) and TubqRv (5 0 -GCTTGGACTTCTTGCCAT AG); and the TBP gene was amplified with the primers TBP 5 0 (5 0 -CCTCTGGTCTTCTTGGCATC) and TBP 3 0 (5 0 -CAACTTCTCCAGCGTCCAGT). TbMaf1 was amplified with oligonucleotides Maf1qFw (5 0 -ATTCTTTGCTTCAGGGT GTG) and Maf1qRv (5 0 -GAAGCCGTATGACGTCCGCTT).
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